The Cellu M6 Kemodule™ that delivers Endermotherapy™ is scientifically proven and FDA cleared for muscular pain relief. LPG has done diagnostic studies with the Cellu M6 and Endermotherapy™ treatments and has found Endermotherapy™ to be an effective form of treatment for muscular pain in Fibromyalgia sufferers. This unique deep tissue action has received the prestigious seal of approval in 2006 from the National Fibromyalgia Association.
LPG Receives National Fibromyalgia Association Seal of Approval. The National Fibromyalgia Association (NFA) has bestowed its prestigious Seal of Approval on LPG’s Cellu M6 Keymodule. Developed by the worldwide leader in connective tissue techniques and technologies, the Cellu M6 is proven in more than 85 scientific studies and cleared by the FDA to improve blood circulation, relieve DOMS (Delayed Onset Muscle Soreness), muscle spasms, aches and pains. The device becomes the only professional-grade technology of its kind to carry the coveted NFA Seal of Approval.
“We are pleased to partner with such an impressive and renowned organization as the NFA," said Michel Van Welden, Chairman and CEO, LPG. "We believe this mutually rewarding alliance will greatly improve the lives of millions of fibromyalgia sufferers, providing them with a new, safe and highly effective natural pain relieving treatment. Such a strategic partnership underscores LPG’s long-term commitment to future research and development for the fibromyalgia community. We're very proud that we can add the NFA to our distinguished roster of non-profit medical partners."
Although most often characterized by crippling and relentless muscle pain, fibromyalgia has great variance and lack of specificity – making it difficult to treat. To date, no drug has been approved by the FDA to treat fibromyalgia. Clinically tested, the patented Cellu M6 Keymodule is the first natural, non-invasive solution allowing professionals to effectively treat fibromyalgia pain.
The Cellu M6 was demonstrated to effectively treat the symptoms of fibromyalgia in a recent study, the results of which were presented at the Sixth World Congress on Myofascial Pain and Fibromyalgia by Dr. Christine Gordon, an Ohio physical medicine and rehabilitation doctor. The study explored the Cellu M6’s ability to reduce pain, fatigue, morning tiredness, work difficulty, stiffness, anxiety and depression. Four of the ten study participants experienced symptom reductions of 80% or more.
The LPG Cellu M6 combines the benefits of manual mobilization with the effortlessness and reliability of its pre-programmed and scientifically validated technology. Gliding across the skin, the Cellu M6 is uniquely able to precisely target the deepest layers of muscles and tissues, providing consistent deep tissue rejuvenation effectively loosening bands of hardened tissue, soothing pain, relaxing tensions and restoring mobility.